Dihydrotetrabenazine
Small moleculeexperimentalImaging agent
Clinical trial activity
8 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
8
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01283347)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Also known as
- 18-fdtbz
- 18f dtbz
- 18f-dtbz
- dtbz
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02599753 | Phase 2 | Aug 1, 2015 | Chang Gung University |
| NCT02195154 | Phase 2 | Nov 1, 2013 | Chang Gung University, Government of Taiwan |
| NCT02059733 | Phase 2 | Feb 1, 2013 | Chang Gung University |
| NCT01838785 | Phase 2 | Jul 1, 2012 | Chang Gung University |
| NCT02039024 | Phase 2 | Mar 1, 2012 | Chang Gung University, Government of Taiwan |
| NCT01556100 | Phase 2 | Nov 1, 2011 | Chang Gung University |
| NCT01759888 | Phase 2 | Aug 1, 2011 | Chang Gung University, Government of Taiwan |
| NCT01283347 | Phase 2 | May 1, 2010 | Chang Gung University |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Gung University | Academic/Hospital | 8 | 8 | 1 | 2010 |
| Government of Taiwan | Government | 3 | 0 | 1 | 2011 |
2 organizations
Page 1 / 1